4 completed. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
Follow propiverine: new trials by email Literature Review of propiverine trials Research Report on propiverine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Propiverine Hydrochloride Extended-Release Capsule for Overactive Bladder Propiverine Hydrochloride, Tolterodine Extended-release Tablet - Overactive Bladder | Phase 3 | Completed | Lee's Pharmaceutical Limited | 324 | 2010-01-01 | 2012-01-25 |
| Efficacy and Tolerability of Propiverine Hydrochloride in Patients With Neurogenic Detrusor Overactivity Propiverine hydrochloride ER (extended release), Propiverine hydrochloride IR (immediate release) - Neurogenic Urinary Bladder Disorder, Urinary Bladder, Neurogenic | Phase 3 | Completed | APOGEPHA Arzneimittel GmbH | 66 | 2004-12-01 | 2012-02-10 |
| Propiverine in Children Suffering From Non-Neurogenic Overactive Bladder and Urinary Incontinence Mictonetten 5 mg, coated tablet, placebo - Overactive Bladder, Urinary Incontinence | Phase 3 | Completed | APOGEPHA Arzneimittel GmbH | 303 | 2004-06-01 | 2008-01-29 |
| A Study to Evaluate the Efficacy of Tolterodine Prolonged Release Compared With Propiverine for the Treatment of Korean Patients With Overactive Bladder as Assessed by Ambulatory Urodynamic Monitoring propiverine, tolterodine PR - Urinary Bladder, Overactive | Phase 3 | Completed | Pfizer | 41 | 2003-03-01 | 2008-03-31 |
Urinary Bladder, Overactive (4) · Urinary Incontinence (2) · Urinary Bladder, Neurogenic (1) · Urinary Incontinence, Urge (1) · Urologic Diseases (1)
APOGEPHA Arzneimittel GmbH (2) · Lee's Pharmaceutical Limited (1) · Pfizer (1)
Austria (1) · China (1) · Germany (1) · Romania (1) · South Korea (1)
Benjamin Li, PhD (1) · Daniela Marschall-Kehrel, MD (1)